| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.1987.00370060050010 |
| P698 | PubMed publication ID | 3496062 |
| P2093 | author name string | Strom BL | |
| Morse ML | |||
| Stolley PD | |||
| Soper KA | |||
| Carson JL | |||
| Jones JK | |||
| West SL | |||
| P433 | issue | 6 | |
| P921 | main subject | toxicity | Q274160 |
| P304 | page(s) | 1054-1059 | |
| P577 | publication date | 1987-06-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs | |
| P478 | volume | 147 |
| Q67919629 | Acid Peptic Disease in the Elderly |
| Q24804373 | COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred |
| Q33701242 | Channelling of controlled release formulation of ketoprofen (Oscorel) in patients with history of gastrointestinal problems |
| Q39469724 | Choice of non-steroidal anti-inflammatory drug in persons treated for dyspepsia |
| Q36641159 | Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing |
| Q55071130 | Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. |
| Q33770765 | Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis |
| Q28335522 | Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers |
| Q40679153 | Differences in NSAID tolerability profiles. Fact or fiction? |
| Q28175558 | Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement |
| Q42871722 | Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm |
| Q40661010 | Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs |
| Q41757692 | Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury |
| Q38254644 | Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies |
| Q40466622 | From peptic ulcer disease to NSAID gastropathy. An evolving nosology. |
| Q71605023 | Gastric tolerability of nimesulide. A double-blind comparison of 2 oral dosage regimens and placebo |
| Q36214082 | Gastroprotection and nonsteroidal anti-inflammatory drugs (NSAIDS). Rationale and clinical implications |
| Q40392368 | Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use. |
| Q37262981 | Histological findings in gastric mucosa in patients treated with non-steroidal anti-inflammatory drugs |
| Q34310573 | Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project) |
| Q35920722 | Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs |
| Q38097424 | Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy |
| Q33560264 | Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs |
| Q72073597 | Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases |
| Q38627221 | Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management |
| Q34134281 | Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Mechanisms of protection and healing: current knowledge and future research |
| Q39403304 | Nonsteroidal antiinflammatory drugs and upper gastrointestinal hemorrhage in an urban hospital |
| Q73502258 | Nonsteroidal antiinflammatory drugs, ulcers and risk:A collaborative meta-analysis |
| Q38733847 | Pharmaco-epidemiological perspectives |
| Q33573619 | Pharmacoeconomics of chronic nonmalignant pain |
| Q68201172 | Poisoning with equine phenylbutazone in a racetrack worker |
| Q34377747 | Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis |
| Q22306448 | Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? |
| Q43492439 | Ranitidine prevents duodenal ulcers associated with non-steroidal anti-inflammatory drug therapy |
| Q71957496 | Rational use of NSAIDs for musculoskeletal disorders |
| Q46924071 | Recent considerations in nonsteroidal anti-inflammatory drug gastropathy |
| Q40587138 | Rheumatoid arthritis: new approaches for its evaluation and management |
| Q33954543 | Rheumatology: 7. Basics of therapy |
| Q37611782 | Risk factors for adverse drug reactions--epidemiological approaches |
| Q72674958 | Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs |
| Q57386566 | Side-effects of non-steroidal anti-inflammatory drugs |
| Q35000410 | The COX-2 inhibitors: new analgesic and anti-inflammatory drugs |
| Q39560477 | The basis for variability of response to anti-rheumatic drugs |
| Q34034067 | The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs: a review of the literature |
| Q37717322 | The management of NSAID gastropathy |
| Q36067762 | The treatment of osteoarthritis |
| Q41526041 | Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor? |
| Q28185419 | Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden? |
| Q74509832 | Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs |
| Q24655364 | Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis |
Search more.